{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:26:53Z","timestamp":1782476813011,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00467-023-06084-9","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T04:01:50Z","timestamp":1689998510000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension"],"prefix":"10.1007","volume":"39","author":[{"given":"Yarden","family":"Bulkowstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Nitzan\u2011Luques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviad","family":"Schnapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Barnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Gilboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-1045","authenticated-orcid":false,"given":"Oded","family":"Volovesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"key":"6084_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","volume":"71","author":"M Wall","year":"2014","unstructured":"Wall M, Kupersmith MJ, Kieburtz KD et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693\u2013701. https:\/\/doi.org\/10.1001\/jamaneurol.2014.133","journal-title":"JAMA Neurol"},{"key":"6084_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archneur.1982.00510200003001","volume":"39","author":"JJ Corbett","year":"1982","unstructured":"Corbett JJ, Savino PJ, Thompson HS et al (1982) Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 39:461\u2013474. https:\/\/doi.org\/10.1001\/archneur.1982.00510200003001","journal-title":"Arch Neurol"},{"key":"6084_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/01.wnl.0000251312.19452.ec","volume":"68","author":"M Thambisetty","year":"2007","unstructured":"Thambisetty M, Lavin PJ, Newman NJ et al (2007) Fulminant idiopathic intracranial hypertension. Neurology 68:229\u2013232. https:\/\/doi.org\/10.1212\/01.wnl.0000251312.19452.ec","journal-title":"Neurology"},{"key":"6084_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pediatrneurol.2019.04.018","volume":"101","author":"A Hilely","year":"2019","unstructured":"Hilely A, Hecht I, Goldenberg-Cohen N et al (2019) Long-Term Follow-up of Pseudotumor Cerebri Syndrome in Prepubertal Children, Adolescents, and Adults. Pediatr Neurol 101:57\u201363. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.04.018","journal-title":"Pediatr Neurol"},{"key":"6084_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1177\/0333102413484095","volume":"33","author":"J Hoffmann","year":"2013","unstructured":"Hoffmann J, Huppertz HJ, Schmidt C et al (2013) Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. Cephalalgia 33:1075\u20131084. https:\/\/doi.org\/10.1177\/0333102413484095","journal-title":"Cephalalgia"},{"key":"6084_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.crad.2011.12.002","volume":"67","author":"PJ Maralani","year":"2012","unstructured":"Maralani PJ, Hassanlou M, Torres C et al (2012) Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol 67:656\u2013663. https:\/\/doi.org\/10.1016\/j.crad.2011.12.002","journal-title":"Clin Radiol"},{"key":"6084_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1258\/ar.2012.110705","volume":"53","author":"SR Butros","year":"2012","unstructured":"Butros SR, Goncalves LF, Thompson D et al (2012) Imaging features of idiopathic intracranial hypertension, including a new finding: widening of the foramen ovale. Acta Radiol 53:682\u2013688. https:\/\/doi.org\/10.1258\/ar.2012.110705","journal-title":"Acta Radiol"},{"key":"6084_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81:1159\u20131165. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a55f17","journal-title":"Neurology"},{"key":"6084_CR9","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1542\/pir.28-11-e77","volume":"28","author":"G Mercille","year":"2007","unstructured":"Mercille G, Ospina LH (2007) Pediatric Idiopathic Intracranial Hypertension: A Review. Pediatr Rev 28:e77\u2013e86. https:\/\/doi.org\/10.1542\/pir.28-11-e77","journal-title":"Pediatr Rev"},{"key":"6084_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","volume":"15","author":"KA Markey","year":"2016","unstructured":"Markey KA, Mollan SP, Jensen RH et al (2016) Understanding idiopathic intracranial hypertension: Mechanisms, management, and future directions. Lancet Neurol 15:78\u201391. https:\/\/doi.org\/10.1016\/S1474-4422(15)00298-7","journal-title":"Lancet Neurol"},{"key":"6084_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2010.08.001","volume":"43","author":"SM Standridge","year":"2010","unstructured":"Standridge SM (2010) Idiopathic intracranial hypertension in children: A review and algorithm. Pediatr Neurol 43:377\u2013390. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2010.08.001","journal-title":"Pediatr Neurol"},{"key":"6084_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S1474-4422(06)70442-2","volume":"5","author":"AK Ball","year":"2006","unstructured":"Ball AK, Clarke CE (2006) Idiopathic intracranial hypertension. Lancet Neurol 5:433\u2013442. https:\/\/doi.org\/10.1016\/S1474-4422(06)70442-2","journal-title":"Lancet Neurol"},{"key":"6084_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1212\/WNL.40.12.1859","volume":"40","author":"M Wall","year":"1990","unstructured":"Wall M (1990) Sensory visual testing in idiopathic intracranial hypertension: measures sensitive to change. Neurology 40:1859\u20131864. https:\/\/doi.org\/10.1212\/WNL.40.12.1859","journal-title":"Neurology"},{"key":"6084_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC et al (2018) Idiopathic intracranial hypertension: Consensus guidelines on management. J Neurol Neurosurg Psychiatry 89:1088\u20131100. https:\/\/doi.org\/10.1136\/jnnp-2017-317440","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6084_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ophtha.2004.11.049","volume":"112","author":"DD Thuente","year":"2005","unstructured":"Thuente DD, Buckley EG (2005) Pediatric optic nerve sheath decompression. Ophthalmology 112:724\u2013727. https:\/\/doi.org\/10.1016\/j.ophtha.2004.11.049","journal-title":"Ophthalmology"},{"key":"6084_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pediatrneurol.2016.08.010","volume":"66","author":"SC Aylward","year":"2017","unstructured":"Aylward SC, Reem RE (2017) Pediatric Intracranial Hypertension. Pediatr Neurol 66:32\u201343. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2016.08.010","journal-title":"Pediatr Neurol"},{"key":"6084_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1600-0404.2007.00905.x","volume":"116","author":"N \u00c7elebisoy","year":"2007","unstructured":"\u00c7elebisoy N, G\u00f6k\u00e7ay F, \u015eirin H et al (2007) Treatment of idiopathic intracranial hypertension: Topiramate vs Acetazolamide, an open-label study. Acta Neurol Scand 116:322\u2013327. https:\/\/doi.org\/10.1111\/j.1600-0404.2007.00905.x","journal-title":"Acta Neurol Scand"},{"key":"6084_CR18","first-page":"194","volume":"189","author":"KD McCarthy","year":"1974","unstructured":"McCarthy KD, Reed DJ (1974) The effect of Acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 189:194\u2013201","journal-title":"J Pharmacol Exp Ther"},{"key":"6084_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/head.13144","volume":"57","author":"SV Smith","year":"2017","unstructured":"Smith SV, Friedman DI (2017) The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes. Headache 57:1303\u20131310. https:\/\/doi.org\/10.1111\/head.13144","journal-title":"Headache"},{"key":"6084_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ajo.2017.01.004","volume":"176","author":"M Wall","year":"2017","unstructured":"Wall M, Kupersmith MJ, Thurtell MJ et al (2017) The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes from Months 6\u201312. Am J Ophthalmol 176:102\u2013107. https:\/\/doi.org\/10.1016\/j.ajo.2017.01.004","journal-title":"Am J Ophthalmol"},{"key":"6084_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2146\/ajhp170279","volume":"75","author":"MA Van Berkel","year":"2018","unstructured":"Van Berkel MA, Elefritz JL (2018) Evaluating off-label uses of acetazolamide. Am J Health Syst Pharm 75:524\u2013531. https:\/\/doi.org\/10.2146\/ajhp170279","journal-title":"Am J Health Syst Pharm"},{"key":"6084_CR22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2014.3312","volume":"311","author":"M Wall","year":"2014","unstructured":"Wall M, McDermott MP, Kieburtz KD et al (2014) Effect of Acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 311:1641\u20131651. https:\/\/doi.org\/10.1001\/jama.2014.3312","journal-title":"JAMA"},{"key":"6084_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/ham.2008.1029","volume":"9","author":"MC Van Patot","year":"2008","unstructured":"Van Patot MC, Leadbetter G, Keyes LE et al (2008) Prophylactic low-dose Acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol 9:289\u2013293. https:\/\/doi.org\/10.1089\/ham.2008.1029","journal-title":"High Alt Med Biol"},{"key":"6084_CR24","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2016.8.FOCUS16278","volume":"41","author":"JK Karimy","year":"2016","unstructured":"Karimy JK, Duran D, Hu JK et al (2016) Cerebrospinal fluid hypersecretion in pediatric hydrocephalus. Neurosurg Focus 41:E10. https:\/\/doi.org\/10.3171\/2016.8.FOCUS16278","journal-title":"Neurosurg Focus"},{"key":"6084_CR25","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nm.4361","volume":"23","author":"JK Karimy","year":"2017","unstructured":"Karimy JK, Zhang J, Kurland DB et al (2017) Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus. Nat Med 23:997\u20131003. https:\/\/doi.org\/10.1038\/nm.4361","journal-title":"Nat Med"},{"key":"6084_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/13543776.2018.1519023","volume":"28","author":"CT Supuran","year":"2018","unstructured":"Supuran CT (2018) Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. Expert Opin Ther Pat 28:713\u2013721. https:\/\/doi.org\/10.1080\/13543776.2018.1519023","journal-title":"Expert Opin Ther Pat"},{"key":"6084_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/14737175.2015.1066675","volume":"15","author":"CT Supuran","year":"2015","unstructured":"Supuran CT (2015) Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother 15:851\u2013856. https:\/\/doi.org\/10.1586\/14737175.2015.1066675","journal-title":"Expert Rev Neurother"},{"key":"6084_CR28","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ana.25457","volume":"85","author":"AF Mart\u00ednez-Monseny","year":"2019","unstructured":"Mart\u00ednez-Monseny AF, Bolasell M, Callej\u00f3n-P\u00f3o L et al (2019) AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). Ann Neurol 85:740\u2013751. https:\/\/doi.org\/10.1002\/ana.25457","journal-title":"Ann Neurol"},{"key":"6084_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/wno.0000000000000516","volume":"37","author":"E Tovia","year":"2017","unstructured":"Tovia E, Reif S, Oren A, Mitelpunkt A et al (2017) Treatment Response in Pediatric Patients with Pseudotumor Cerebri Syndrome. J Neuroophthalmol 37:393\u2013397. https:\/\/doi.org\/10.1097\/wno.0000000000000516","journal-title":"J Neuroophthalmol"},{"key":"6084_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3129\/i09-198","volume":"45","author":"S Sharan","year":"2010","unstructured":"Sharan S, Dupuis A, H\u00e9bert D et al (2010) The effect of oral Acetazolamide on weight gain in children. Can J Ophthalmol 45:41\u201345. https:\/\/doi.org\/10.3129\/i09-198","journal-title":"Can J Ophthalmol"},{"key":"6084_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.pediatrneurol.2014.05.027","volume":"51","author":"JM Markhorst","year":"2014","unstructured":"Markhorst JM, Stunnenberg BC, Ginjaar IB et al (2014) Clinical experience with long-term acetazolamide treatment in children with nondystrophic myotonias: a three-case report. Pediatr Neurol 51:537\u2013541. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2014.05.027","journal-title":"Pediatr Neurol"},{"key":"6084_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/WNO.0000000000000322","volume":"36","author":"MW ten Hove","year":"2016","unstructured":"ten Hove MW, Friedman DI, Patel AD et al (2016) Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol 36:13\u201319. https:\/\/doi.org\/10.1097\/WNO.0000000000000322","journal-title":"J Neuroophthalmol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06084-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06084-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06084-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T11:06:33Z","timestamp":1700823993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06084-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6084"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06084-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"25 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}